INCLUSION OF A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A UK PERSPECTIVE

被引：4
|
作者：
Soubieres, A. [1 ]
Pimentel, M. [2 ]
Purdy, C. [3 ]
Magar, R. [4 ]
机构：
[1] St Georges Healthcare NHS Trust, London, England
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] AHRM Inc, Buffalo, NY USA
[4] AHRM Inc, Raleigh, NC USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.634
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD33
引用
收藏
页码：A350 / A350
页数：1
相关论文
共 50 条
  • [1] POTENTIAL FOR COST SAVINGS ASSOCIATED WITH A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): ITALIAN PERSPECTIVE
    Gabbani, T.
    Violanti, C.
    Deiana, S.
    Pimentel, M.
    Purdy, C.
    Magar, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A349 - A350
  • [2] Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction
    Habba, Saad F.
    [J]. MEDICAL HYPOTHESES, 2011, 76 (01) : 97 - 99
  • [3] IMPACT OF A NOVEL IBS DIAGNOSTIC BLOOD PANEL FOR MEXICO: COST IMPLICATIONS TO THE MEXICAN PRIVATE PRACTICE FOR DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D)
    Schmulson, M. J.
    Castillo Barradas, M.
    Pimentel, M.
    Magar, R.
    Purdy, C.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A350 - A350
  • [4] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [5] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [6] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [7] A NOVEL IBS DIAGNOSTIC BLOOD PANEL CAN ENHANCE A POSITIVE DIAGNOSTIC STRATEGY VERSUS A STRATEGY OF EXCLUSION FOR PATIENTS WITH DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): COST IMPLICATIONS FOR DENMARK
    Purdy, C.
    Bytzer, P. M.
    Pimentel, M.
    Magar, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A350 - A350
  • [8] AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Carrasco-Labra, Alonso
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    Surawicz, Christina M.
    Chey, William D.
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 859 - 880
  • [9] The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)
    Min, Yang Won
    Rhee, Poong-Lyul
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (03) : 136 - 142
  • [10] Burden of Disease in US Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Xu, Yanqing
    Taylor, Douglas C.
    Kosch, Katherine J.
    Dobrescu, Rachel
    Morlock, Amy
    Morlock, Robert
    Rooker, Ceciel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S399 - S400
12345